8GI
SNTI icon

8VC GP I’s Senti Biosciences Holdings SNTI Stock Holding History

8VC GP I’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-253,755
Closed -$358K – 2
2025
Q3 		$358K Hold
253,755
– – 0.46% 2
2025
Q2 		$535K Hold
253,755
– – 0.53% 2
2025
Q1 		$853K Hold
253,755
– – 1.45% 2
2024
Q4 		$891K Hold
253,755
– – 1.13% 2
2024
Q3 		$573K Sell
253,755
-1
-0% -$3 0.78% 2
2024
Q2 		$7M Hold
253,756
– – 8.67% 2
2024
Q1 		$957K Hold
253,756
– – 1.22% 2
2023
Q4 		$1.67M Buy
+253,756
New +$990K 1.71% 2

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MG
MSOP GP Menlo Park, California $439M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

8VC GP I's SNTI Position: Q4 2025 in Review

8VC GP I sold out of Senti Biosciences Holdings (SNTI) in Q4 2025, closing a stake of 253,755 shares — an estimated $358K sold.

8VC GP I first reported a position in SNTI in Q4 2023 and held it in 8 quarters. The position peaked at $7M in Q2 2024. 15 funds tracked by Wall St. Rank hold SNTI as of Q4 2025.

  • 8VC GP I reported no remaining Senti Biosciences Holdings position as of Q4 2025 after selling out during the quarter.
  • 8VC GP I sold 253,755 Senti Biosciences Holdings shares in Q4 2025, an estimated $358K.
  • 8VC GP I first reported a position in Senti Biosciences Holdings in Q4 2023 and held it in 8 quarters.
  • 8VC GP I's Senti Biosciences Holdings position peaked at $7M in Q2 2024.
  • 15 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2025.

Based on 8VC GP I's 13F filing for Q4 2025, filed 18 Feb 2026.